92 related articles for article (PubMed ID: 9190984)
1. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer.
Lambert-Messerlian GM; Steinhoff M; Zheng W; Canick JA; Gajewski WH; Seifer DB; Schneyer AL
Gynecol Oncol; 1997 Jun; 65(3):512-6. PubMed ID: 9190984
[TBL] [Abstract][Full Text] [Related]
2. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG
J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327
[TBL] [Abstract][Full Text] [Related]
3. Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in women with idiopathic premature ovarian failure.
Munz W; Hammadeh ME; Seufert R; Schaffrath M; Schmidt W; Pollow K
Fertil Steril; 2004 Sep; 82(3):760-2. PubMed ID: 15374731
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
[TBL] [Abstract][Full Text] [Related]
6. Inhibin A, B and pro-alphaC in serum and peritoneal fluid in postmenopausal patients with ovarian tumors.
Ala-Fossi SL; Mäenpää J; Bläuer M; Tuohimaa P; Punnonen R
Eur J Endocrinol; 2000 Apr; 142(4):334-9. PubMed ID: 10754473
[TBL] [Abstract][Full Text] [Related]
7. Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma.
Menon U; Riley SC; Thomas J; Bose C; Dawnay A; Evans LW; Groome NP; Jacobs IJ
BJOG; 2000 Sep; 107(9):1069-74. PubMed ID: 11002947
[TBL] [Abstract][Full Text] [Related]
8. [Role of total inhibin in diagnosis and monitoring of ovarian cancer in postmenopausal women].
Markova D; Milchev N; Batashki I; Uchikov A
Akush Ginekol (Sofiia); 2008; 47(1):16-9. PubMed ID: 18642569
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay of total inhibin: direct determination based on inhibin alpha subunit-specific monoclonal antibodies.
Khosravi J; Krishna RG; Khaja N; Bodani U; Diamandi A
Clin Biochem; 2004 May; 37(5):370-6. PubMed ID: 15087252
[TBL] [Abstract][Full Text] [Related]
10. Inhibin as a diagnostic marker for ovarian cancer.
Robertson DM; Pruysers E; Jobling T
Cancer Lett; 2007 Apr; 249(1):14-7. PubMed ID: 17320281
[TBL] [Abstract][Full Text] [Related]
11. [Inhibin and ovarian cancer].
Burger HG; Baillie A; Drummond AE; Healy DL; Jobling T; Mamers P; Robertson DM; Susil B; Cahir N; Shen Y; Verity K; Fuller PJ; Groome NP; Findlay JK
Vopr Onkol; 1999; 45(4):369-73. PubMed ID: 10532093
[TBL] [Abstract][Full Text] [Related]
12. Total inhibin is a potential serum marker for epithelial ovarian cancer.
Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F
J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
14. Inhibin forms in serum from postmenopausal women with ovarian cancers.
Robertson DM; Cahir N; Burger HG; Mamers P; Groome N
Clin Endocrinol (Oxf); 1999 Mar; 50(3):381-6. PubMed ID: 10435065
[TBL] [Abstract][Full Text] [Related]
15. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
16. Increased serum inhibin B levels in postmenopausal women with altered thyroid function.
Viceconti N; Luisi S; Nardo S; Gargano L; Franchi A; Sibilla R; Canettieri G; Petraglia F; Centanni M
Horm Metab Res; 2003 Aug; 35(8):498-501. PubMed ID: 12953168
[TBL] [Abstract][Full Text] [Related]
17. Combined inhibin and CA125 assays in the detection of ovarian cancer.
Robertson DM; Cahir N; Burger HG; Mamers P; McCloud PI; Pettersson K; McGuckin M
Clin Chem; 1999 May; 45(5):651-8. PubMed ID: 10222351
[TBL] [Abstract][Full Text] [Related]
18. Molecular weight forms of inhibin A, inhibin B and pro-alphaC in maternal serum, amniotic fluid and placental extracts of normal and Down syndrome pregnancies.
Thirunavukarasu PP; Lambert-Messerlian G; Robertson DM; Dawson G; Canick J; Wallace EM
Prenat Diagn; 2002 Dec; 22(12):1086-92. PubMed ID: 12454963
[TBL] [Abstract][Full Text] [Related]
19. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of inhibin in granulosa cell tumors of the ovary.
Jobling T; Mamers P; Healy DL; MacLachlan V; Burger HG; Quinn M; Rome R; Day AJ
Gynecol Oncol; 1994 Nov; 55(2):285-9. PubMed ID: 7959297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
